Cornea/External Disease News

VIENNA — In this Healio Video Perspective from the ESCRS meeting, Soosan Jacob, MS, FRCS, DNB, speaks about her technique for customized corneal allogenic intrastromal ring segments for the treatment of ectatic disorders.

LAS VEGAS — The recent FDA approval of Ryzumvi for the reversal of drug-induced mydriasis has created the opportunity to perform more dilated, comprehensive eye exams, according to Paul M. Karpecki, OD, FAAO.

VIENNA — Therapeutic PRK guided by the CSO MS-39 device for anterior segment analysis allows for customized, tissue-sparing treatment of irregular corneas.

The Twin Cities Ocular Surface Disease Symposium, to be held Oct. 21 and 22 in Minneapolis, will offer 12 hours of accredited continuing education for eye care professionals, the symposium’s founder, Ahmad Fahmy, OD, FAAO, told Healio.

VIENNA — In this Healio Video Perspective from the ESCRS meeting, José Vargas, MD, speaks about his experience as a surgeon and as a patient who recently underwent cataract surgery.

OKYO Pharma has completed patient enrollment for the randomized portion of its phase 2 clinical trial of OK-101, a topical treatment for dry eye disease, the company announced in a press release.

VIENNA — In this Healio Video Perspective from the ESCRS meeting, Farhad Hafezi, MD, PhD, speaks about PACE, short for PTK-assisted customized epi-on cross-linking.

NovaBay Pharmaceuticals announced the launch of a prescription optic allograft for protecting the ocular surface, made with BioStem Technologies’ proprietary process.

VIENNA — At the ESCRS meeting, Jorge L. Alió, MD, PhD, received the Binkhorst Medal, an important achievement in his professional career.

The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products, the agency announced in a press release.